Optiscan Imaging Ltd

Optiscan Imaging Ltd is a global medical technology company focused on developing, manufacturing, and commercializing confocal endomicroscopic imaging technologies. The company is listed on the ASX (ASX: OIL) and is recognized for its contributions to digital pathology and precision surgery. Optiscan's innovative imaging solutions enable real-time, non-destructive, 3D digital imaging at the single-cell level, which is particularly beneficial for early disease detection and management, especially in cancer care. The company's core technology includes miniaturized digital endomicroscopes that provide imaging resolution significantly greater than traditional CT and MRI scans. Key products include the InVivage digital imaging platform for live tissue visualization and the ViewnVivo handheld confocal endomicroscope for real-time imaging. Optiscan's solutions are utilized in medical diagnostics, translational research, and pre-clinical studies, supporting healthcare providers and researchers in making informed decisions during procedures. With a global presence, Optiscan serves hospitals, research institutions, and medical device partners, contributing to advancements in healthcare and improving patient outcomes.

• Employees 8
• Founded 1994
• Annual Revenue $2434000
• Total Funding $3690000